<DOC>
	<DOCNO>NCT01841060</DOCNO>
	<brief_summary>Lung tumor non-small cell stage 1A usually treat surgically many patient operable condition respiratory problem associate . The treatment suggest local radiotherapy conventionally carry split mode 6 week dose 60-65 Gy irradiation mode This expose patient complication , include post-radiation pneumonitis .</brief_summary>
	<brief_title>Assessment Effectiveness Local Ablathermy Radio Frequency Bronchial Tumors Primitive</brief_title>
	<detailed_description>Lung tumor non-small cell stage 1A usually treat surgically many patient operable condition respiratory problem associate . The treatment suggest local radiotherapy conventionally carry split mode 6 week dose 60-65 Gy irradiation mode This expose patient complication , include post-radiation pneumonitis . This problematic patient respiratory failure surgical treatment challenge . Radiofrequency pulmonary develop therapeutic alternative , advantage perform session less toxicity lung parenchyma</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Bronchial Neoplasms</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients 18 year 2 . Histological diagnosis nonsmall cell lung tumor establish . 3 . Stage 1A tumor ( lesion &lt; = 3 cm , N0 ) report prepare PET CT 4 . Surgical treatment lesion contrindiqu√© refuse patient , 5 . ARF consider technically feasible discuss case multidisciplinary meeting ( RCP ) 6 . Expectancy great 6 month life 7 . PET inclusion ( 8 week maximum radiofrequency ) show uptake ( SUV &gt; = 2.5 ) lesion treat , 8 . Signed informed consent , 9 . Patient affiliate social security scheme . Exclusion criterion : 1 . Location lesion allow achieve ablathermy satisfactory condition : lesion contiguous major anatomical structure mediastinum , hilar location ( le 1 cm hilum ) 2 . Disorder uncontrolled bleeding ( TP &lt; 50 % TCA &gt; 1.5 x control ) . 3 . Abnormal blood count platelet &lt; 90000/mm3 4 . Consindication general anesthesia 5 . Patient cardiac pacemaker review indicate treatment ARF 6. pregnancy 7 . Patient include another clinical study 8 . Unable undergo medical monitoring test geographical , social psychological reason , 9 . Private patient freedom major subject measure legal protection unable consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Malignant Non-small Cell Neoplasm Lung</keyword>
</DOC>